Cholesterol Efflux and Atheroprotection

Scott Turner, Jason Voogt, Michael H. Davidson, Alex Glass, Salena Killion, J Decaris, Hussein Mohammed, Kaori Minehira, Drina Boban, Elizabeth J. Murphy, Jayraz Luchoomun, Mohamad Awada, Richard A. Neese, Marc Hellerstein

Article2010

5A Apolipoprotein Mimetic Peptide Promotes Cholesterol Efflux and Reduces Atherosclerosis in Mice

Marcelo Amar, Wilissa D’Souza, Scott Turner, Stephen J. Demosky, Denis Sviridov, John A. Stonik, Jayraz Luchoomun, Jason Voogt, Marc Hellerstein, Dmitri Sviridov, Alan T. Remaley

Article2010

In vivo Tissue Cholesterol Efflux is Impaired in Carriers of Mutations in APOA1 and ABCA1

Adriaan G. Holleboom, Remco Franssen, Lily Jakulj, J Decaris, Menno Vergeer, Joris Koetsveld, Marc Hellerstein, John J.P. Kastelein, Albert K. Groen, Scott Turner, Erik S.G. Stroes

Article2013

In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1

Adriaan G. Holleboom, Lily Jakulj, Remco Franssen, J Decaris, Menno Vergeer, Joris Koetsveld, Jayraz Luchoomun, Alexander Glass, Marc Hellerstein, John J.P. Kastelein, G. Kees Hovingh, Jan Albert Kuivenhoven, Albert K. Groen, Scott Turner, Erik S.G. Stroes

Article2019

Abstract 504: Association of Exercise-Induced Changes in Cholesterol Efflux Capacity with Changes in the HDL Proteome

Jacob L. Barber, Jonathan J. Ruiz‐Ramie, W.A. Clarkson, Michael Olivier, Claude Bouchard, Anand Rohatgi, Mark A. Sarzynski

Arteriosclerosis Thrombosis and Vascular Biology